申请人:GLAXO GROUP LTD
公开号:WO2010070021A1
公开(公告)日:2010-06-24
The present invention relates to compounds of formula (I) or pharmaceutically acceptable salts or solvates thereof, processes for their preparation, pharmaceutical compositions containing these compounds, and their use in the treatment of allergic disorders, such as allergic rhinitis and asthma.
本发明涉及式(I)的化合物或其药用盐或溶剂化合物,其制备方法,含有这些化合物的药物组合物,以及它们在治疗过敏性疾病,如过敏性鼻炎和哮喘中的用途。